{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:34:02Z","timestamp":1793144042669,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/ijg.0b013e3180575202","type":"journal-article","created":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T03:01:42Z","timestamp":1186714902000},"page":"471-478","source":"Crossref","is-referenced-by-count":43,"title":["Glaucoma in the United States and Europe"],"prefix":"10.1097","volume":"16","author":[{"given":"Paul P.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo E.","family":"Traverso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Siegartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210208","first-page":"5","article-title":"Preferred Practice Pattern\u2122: Primary Open-angle Glaucoma","author":"Caprioli","year":"2000"},{"key":"R2-8-20210208","first-page":"28","article-title":"Epidemiological aspects, development and management of prevention in ophthalmology in relation to different ages","volume":"37","author":"Nuzzi","year":"1995","journal-title":"Panminerva Med"},{"key":"R3-8-20210208","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","article-title":"Number of people with glaucoma worldwide","volume":"80","author":"Quigley","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"R4-8-20210208","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00061198-200106000-00007","article-title":"Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands","volume":"10","author":"Oostenbrink","year":"2001","journal-title":"J Glaucoma"},{"key":"R5-8-20210208","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00061198-200212000-00015","article-title":"Health economics, economic evaluation, and glaucoma","volume":"11","author":"Kobelt","year":"2002","journal-title":"J Glaucoma"},{"key":"R6-8-20210208","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archopht.121.9.1303","article-title":"Longitudinal prevalence of major eye diseases","volume":"121","author":"Lee","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R7-8-20210208","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00061198-200312000-00002","article-title":"Cost of glaucoma in Canada: analyses based on visual field and physician's assessment","volume":"12","author":"Iskedjian","year":"2003","journal-title":"J Glaucoma"},{"key":"R8-8-20210208","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0266462399015299","article-title":"Modeling cost of treatment with new topical treatments for glaucoma. Results from France and the United Kingdom","volume":"15","author":"Kobelt","year":"1999","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"R9-8-20210208","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/112067210301304S02","article-title":"Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year","volume":"13","author":"Rouland","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"R10-8-20210208","first-page":"6","article-title":"The cost of glaucoma in the United States in 1988","volume":"10","author":"Glick","year":"1994","journal-title":"Chibret Int J Ophthalmol"},{"key":"R11-8-20210208","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s004170050165","article-title":"Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany","volume":"236","author":"Kobelt","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-8-20210208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00061198-199804000-00006","article-title":"Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States","volume":"7","author":"Kobelt-Nguyen","year":"1998","journal-title":"J Glaucoma"},{"key":"R13-8-20210208","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9394(03)00102-8","article-title":"Medical therapy cost considerations for glaucoma","volume":"136","author":"Fiscella","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R14-8-20210208","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00061198-200208000-00013","article-title":"Cost analysis of glaucoma medications: a 3-year review","volume":"11","author":"Vold","year":"2002","journal-title":"J Glaucoma"},{"issue":"4","key":"R15-8-20210208","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1177\/112067210301304S04","article-title":"Clinical and economic impacts of latanoprost 0.005% in first-line treatment of open-angle glaucoma and ocular hypertension in France","volume":"13","author":"Bernard","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"R16-8-20210208","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1517\/14656566.4.10.1775","article-title":"Assessing the cost-effectiveness of switching from a beta-blocker to latanoprost in the treatment of ocular hypertension","volume":"4","author":"Costagliola","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"R18-8-20210208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajo.2005.07.044","article-title":"Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease","volume":"141","author":"Mills","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R19-8-20210208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.124.1.12","article-title":"A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma","volume":"124","author":"Lee","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R20-8-20210208","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2005.067355","article-title":"Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe","volume":"89","author":"Traverso","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R27-8-20210208","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0420.2001.790315.x","article-title":"Costs of medical and surgical treatment of glaucoma","volume":"79","author":"Calissendorff","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"R28-8-20210208","article-title":"Drug Topics Red Book","author":"Cardinale","year":"2001"},{"key":"R29-8-20210208","article-title":"pub. Medical Fees in the United States. Nationwide Charges for Medicine, Surgery, Laboratory, Radiology, and Allied Health Services","author":"Davis","year":"2001"},{"key":"R30-8-20210208","first-page":"365","article-title":"The glaucomas","volume":"92","author":"Coleman","year":"2001","journal-title":"Minerva Med"},{"key":"R31-8-20210208","first-page":"83","article-title":"Models of open-angle glaucoma prevalence and incidence in the United States","volume":"38","author":"Quigley","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-8-20210208","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bjo.84.5.456","article-title":"The Bristol shared care glaucoma study: outcome at follow up at 2 years","volume":"84","author":"Gray","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R33-8-20210208","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/bjo.86.9.978","article-title":"Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom","volume":"86","author":"Kroese","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R34-8-20210208","first-page":":163","article-title":"L'epdimeiologia in Italia","author":"Cerulli","year":"1997"},{"key":"R35-8-20210208","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000050823","article-title":"The relationship between intraocular pressure and glaucoma in a defined population. Data from the Egna-Neumarkt Glaucoma Study","volume":"215","author":"Bonomi","year":"2001","journal-title":"Ophthalmologica"},{"key":"R36-8-20210208","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000027415","article-title":"Blindness incidence in Germany. A population-based study from Wurttemberg-Hohenzollern","volume":"213","author":"Krumpaszky","year":"1999","journal-title":"Ophthalmologica"},{"key":"R37-8-20210208","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1167\/iovs.02-0304","article-title":"Incidence of blindness in southern Germany due to glaucoma and degenerative conditions","volume":"44","author":"Trautner","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R38-8-20210208","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM199810293391808","article-title":"Medical management of glaucoma","volume":"339","author":"Alward","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"R39-8-20210208","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0039-6257(03)00009-2","article-title":"Achieving low target pressures with today's glaucoma medications","volume":"48","author":"Cantor","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"R40-8-20210208","first-page":"115","article-title":"Glaucoma medications, glaucoma therapy, and the evolving paradigm","volume":"69","author":"Fingeret","year":"1998","journal-title":"J Am Optom Assoc"},{"key":"R41-8-20210208","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0161-6420(02)01075-8","article-title":"Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998","volume":"109","author":"Paikal","year":"2002","journal-title":"Ophthalmology"},{"issue":"4","key":"R42-8-20210208","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1177\/112067210301304S06","article-title":"Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France","volume":"13","author":"Baudouin","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"R43-8-20210208","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/eye.2001.153","article-title":"Is the role of trabeculectomy in glaucoma management changing?","volume":"15","author":"Whittaker","year":"2001","journal-title":"Eye"},{"key":"R44-8-20210208","first-page":"1","article-title":"Primary Open-angle Glaucoma. Preferred practice Pattern","year":"2000"},{"key":"R45-8-20210208","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archopht.121.6.777","article-title":"Patterns of care for open-angle glaucoma in managed care","volume":"121","author":"Fremont","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R46-8-20210208","first-page":"42","article-title":"Glaucoma","volume":"11","author":"Gricar","year":"1998","journal-title":"Manag Care Interface"},{"key":"R47-8-20210208","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/106002809502907-805","article-title":"Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals","volume":"29","author":"Bradley","year":"1995","journal-title":"Ann Pharmacother"},{"key":"R48-8-20210208","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1001\/jama.287.21.2809","article-title":"Quality of systematic reviews of economic evaluations in health care","volume":"287","author":"Jefferson","year":"2002","journal-title":"JAMA"},{"key":"R49-8-20210208","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(98)91133-2","article-title":"The probability of blindness from open-angle glaucoma","volume":"105","author":"Hattenhauer","year":"1997","journal-title":"Ophthalmology"},{"key":"R50-8-20210208","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R51-8-20210208","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.87.10.1201","article-title":"What is the cost of blindness?","volume":"87","author":"Meads","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R52-8-20210208","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0039-6257(02)00457-5","article-title":"Health care economic analyses and value-based medicine","volume":"48","author":"Brown","year":"2003","journal-title":"Surv Ophthalmol"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00061198-200708000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:50:53Z","timestamp":1786035053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00061198-200708000-00008"}},"subtitle":["Predicting Costs and Surgical Rates Based Upon Stage of Disease"],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e3180575202","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}